The pediatric metabolic syndrome

Minerva Medica

Volumn 99, Issue 3, 2008, Pages 269-287

  Morrison, J A ^a,d   Ford, E S ^b   Steinberger, J ^c  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d Winslow Bldg ^*  (United States)

Author keywords

Child; Insulin; Metabolic syndrome X; Obesity

Indexed keywords

ACUTE PHASE PROTEIN; APOLIPOPROTEIN A1; ATYPICAL ANTIPSYCHOTIC AGENT; C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGRAPHY; CHILDHOOD DISEASE; COHORT ANALYSIS; CORONARY ARTERY BYPASS GRAFT; DYSLIPIDEMIA; GLUCOSE METABOLISM; HEART INFARCTION; HUMAN; HYPERINSULINEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LONGITUDINAL STUDY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; REVIEW; SIDE EFFECT; STROKE; WEIGHT GAIN;

ACUTE-PHASE PROTEINS; ADOLESCENT; ADULT; AGE FACTORS; BLOOD VESSELS; CARDIOVASCULAR DISEASES; CHILD; DYSLIPIDEMIAS; HUMANS; HYPERINSULINISM; HYPERTENSION; INSULIN RESISTANCE; METABOLIC SYNDROME X; OBESITY;

EID: 46449104644     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (151)

1. Reaven GM. Banting Lecture 1988: Role of insulin resistance in human disease. Diabetes1988;37:1595-607.
2. Himsworth H. Diabetes Mellitus: a differentiation into insulin-sensitive and insulin-insensitive types. Lancet1936;1:127-30.
3. Merton Robert K. On the shoulders of giants: A Shandean postscript. (The Vicennial Edition). San Diego, New York, London: Harcourt Brace Jovanovich; 1985
4. Kylin E. Studien über das hypertoniwe-hyperglykamie- hyperurikamiesyndrom. Zentralblatt für innere Med 1923;44:105-25.
5. Glueck CJ, Fallat RW, Tsang R, Buncher CR. Hyperinsulinemia in progeny of parents with myocardial infarction before age 50. Am J Dis Child 1974;127:70-5.
6. Morrison JA, Kelly KA, Mellies MJ, deGroot I, Glueck CJ. Parent-child associations at the upper and lower ranges of plasma cholesterol and triglyceride. Pediatrics1978;62:468-77.
7. Webber LS, Cresanta JL, Voor AW, Berenson GS. Tracking of cardiovascular in school-aged children. J Cron Dis 1983;36:647-60.
8. Newman WP 3rd, Freedman DS, Voors AW, Gard PD, Srinivasan SR, Cresanta JL et al. Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis: the Bogalusa Heart Study. N Engl J Med 1986;314:138-44.
9. Bao W, Srinivasan SR, Wattigney WA, Berenson GS. Persistence of multiple Cardiovascular risk clustering related to syndrome X from childhood to young adulthood. The Bogalusa Heart Study. Arch Intern Med1994;154:1842-7.
10. Jiang X, Srinivasan SR, Bao W, Berenson GS. Association of fasting insulin with longitudinal changes in blood pressure in children and adolescents. The Bogalusa Heart Study. Am J Hypertens 1993;6(7 Pt 1):564-9.
11. Berenson GS, Radhakrishnamurthy B, Bao W, Srinivasan SR. Does adult-onset diabetes mellitus begin in childhood?: the Bogalusa Heart Study. Am J Med Sci 1995;310(Suppl 1):S77-82.
12. Sinaiko AR, Gomez-Marin O, Prineas RJ. Relation of fasting insulin to blood pressure and lipids in adolescents and parents. Hypertension 1997;30:1554-9.
13. Klein DJ, Friedman LA, Harlan WR, Barton BA, Schreiber GB, Cohen RM, et al. Obesity and the development of insulin resistance and impaired fasting glucose in black and white adolescent girls: A longitudinal study. Diabetes Care 2004;27:378-83.
14. Moran A, Jacobs DR Jr, Steinberger J, Hong CP, Prineas R, Luepker R et al. Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes 1999;48:2039-44.
15. Moran A, Jacobs DR Jr, Steinberger J, Cohen P, Hong CP, Prineas R et al. Association between the insulin resistance of puberty and the insulin-like growth factor-1/growth hormone axis. J Clin Endocrinol Metab 2002;87:4817-20.
16. Taittonen L, Uhari M, Nuutinen M, Turtinen J, Pokka T, Åkerblom HK. Insulin and blood pressure among healthy children: Cardiovascular risk in young Finns. Am J Hypertens1996;9:193-9.
17. Odeleye OE, de Courten M, Pettitt DJ, Ravussin E. Fasting hyperinsulinemia is a predictor of increased body weight gain and obesity in Pima Indian children. Diabetes 1997;46:1341-5.
18. Srinivasan SR, Frontini MG, Berenson GS, Longitudinal changes in risk variables of insulin resistance syndrome from childhood to young adulthood in offspring of parents with type 2 diabetes: the Bogalusa Heart Study. Metabolism 2003;52:443-50.
19. Bao W, Srinivasan SR, Berenson GS. Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults: The Bogalusa Heart Study. Circulation 1996;93:54-9.
20. Sinaiko A, Steinberger J, Moran A, Prineas RJ, Jacobs DR. Relation of BMI and insulin resistance to cardiovascular risk factors, inflammatory factors and oxidative stress during adolescence. Circulation 2005;111: 1985-91.
21. Kalkhoff RK, Hartz AH, Rupley D, Kissebah AH, Kelber S. Relationship of body fat distribution to blood pressure, carbohydrate tolerance, and plasma lipids in healthy obese women. J Lab Clin Med 1983;102:621-7.
22. Bao W, Srinivasan SR, Wattiganey WA, Berenson GS. Persistence of multiple cardiovascular risk clustering related to Syndrome X from childhood to young adulthood. The Bogalusa Heart Study. Arch Intern Med1994;154:1842-7.
23. Chen W, Srinivasan SR, Li S, Xu J, Berenson GS. Clustering of long-term trends in metabolic syndrome variables from childhood to adulthood in Blacks and Whites: the Bogalusa Hearst Study. Am J Epidemiol 2007;166:527-33.
24. Alberti KG, Zimmet PZ. Definition, diagnosis, and classification of diabetes and its complications. Part 1: diagnosis and classification of diabetes mellitus: provisional report of a WHO consultation. Diabet Med 1998;15:539-53.
25. World Health Organization Definition, diagnosis, and classification of diabetes and its complications. Geneva Switzerland: World Health Organization; 1999. Report No.:WHO/NCD/NCS/99.2.
26. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. Diabet Med 1999;16:442-43.
27. Expert Panel on Detection, Evaluation, and Treatment of High Cholesterol in adults. Executive Summary of the Third Report of the National Cholesterol Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
28. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. Diagnosis and management of metabolic syndrome: an American Heart Association/National Heart Lung and Blood Institute Scientific Statement. Circulation 2005;112:2735-52.
29. Einhorn D, Reaven GM, Cobin RH, Ford E, Ganda OP, Handelsman Y et al. American College of Endocrinology position statement on the insulin Resistance Syndrome. Endocrin Pract 2003;9:237-52.
30. Alberti K, Zimmet P, Shaw J. The metabolic syndrome - a new worldwide definition. Lancet 2005;366:1059-62.
31. st World Congress on the Insulin Resistance Syndrome. Diabetes Care 2004;27:824-30.
32. Ford ES, Li C. Defining the metabolic syndrome in children and adolescents: will the real definition please stand up? J Pediatr 2008;152:160-4.
33. Goodman E, Daniels SR, Morrison JA, Haung B, Dolan LM. Contrasting prevalence of and demographic disparities in the World Health Organization and National Cholesterol Education Program Adult Treatment Panel III definitions of metabolic syndrome among adolescents. J Pediatr 2004;145:445-51.
34. Zimmet P, Alberti G, Kaufman F, Tajima N, Silink M, Arslanian S et al. The metabolic syndrome in children and adolescents. Lancet 2007;369:2059-61.
35. Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev 1995;75:473-86.
36. Cavaghan MK, Ehrmann DA, Polonsky KS. Interactions between insulin resistance and insulin secretion in the development of glucose intolerance. J Clin Invest 2000;106:329-33.
37. Srinivasan SR, Myers L, Berenson GS. Temporal association between obesity and hyperinsulinemia in children, adolescents, and young adults: The Bogalusa Heart Study. Metabolism1999;49:928-34.
38. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among US adults. Diabetes Care 2004;27:2444-9.
39. rd, Castelli WP. Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med 1987;16:235-51.
40. Garrison RJ, Wilson PW, Castelli WP, Feinleib M, Kannel WB, McNamara PM. Obesity and lipoprotein cholesterol in the Framingham offspring study. Metabolism 1980;29:1053-60.
41. Lamon-Fava S, Wilson PW, Shaefer EJ. Impact of body mass index on coronary heart disease risk factors in men and women: The Framingham Offspring Study. Arterioscler Thromb Vasc Biol 1996;16:1509-15.
42. Liese AD, Mayer-Davis EJ, Tyroler HA, Davis CE, Keil U, Duncan BB et al. Development of the multiple metabolic syndrome in the ARIC cohort: Joint contribution of insulin, BMI, and WHR. Ann Epidemiol 1997;7:407-16.
43. Chen W, Bao W, Begum S, Elkasabany A, Srinivasan SR, Berenson GS. Age-related patterns of the clustering of cardiovascular risk variables of syndrome X from childhood to young adulthood in a population made up of black and white subjects. Diabetes 2000;49:1042-9.
44. Sakkinen Sakkinen PA, Wahl P, Cushman M, Lewis MR, Tracy RP. Clustering of Procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am J Epidemiol 2000;152: 897-907.
45. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001;280:E745-51.
46. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-43.
47. Aquilante CL, Kosmiski LA, Knutsen SD, Zinch I. Relationship between plasma resistin concentrations, inflammatory chemokines, and components of the metabolic syndrome in adults. Metabolism 2008;57:494-501.
48. Sutherland JP, McKinley B, Eckel RH. The metabolic syndrome and inflammation. Metab Syndr Relat Disord 2004;2:82-104.
49. Ventre J, Doebber T, Wu M, MacNaul K, Stevens K, Pasparakis M et al. Targeted disruption of the tumor necrosis factor-alpha gene: metabolic consequences in obese and non-obese mice. Diabetes 1997;46:1526-31.
50. Senn JJ, Klover PJ, Nowak IA, Mooney RA. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 2002;51:3391-9.
51. Mosca CL, Marshall JA, Grunwald GK, Cornier MA, Baxter J. Insulin resistance as a modifier of the relationship between dietary fat intake and weight gain. Int J Obes Relat Metab Disord 2004;28:803-12.
52. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest 2000;106:473-81.
53. Lustig RH. Childhood obesity: behavioral aberration or biochemical drive? Reinterpreting the First Law of Thermodynamics. Nat Clin Pract Endocrinol Metab 2006;2:447-58.
54. Sigal RJ, El-Hashimy M, Martin BC, Soeldner JS, Krolewski AS, Warram JH. Acute postchallenge hyperinsulinemia predicts weight gain: a prospective study. Diabetes 1997;46:1025-9.
55. Schwartz MW, Boyko EJ, Kahn SE, Ravussin E, Bogardus C. Reduced insulin secretion: an independent predictor of body weight gain. J Clin Endocrinol Metab 1995;80:1571-6.
56. Lustig RH, Mietus-Snyder ML, Bacchetti P, Lazar AA, Velasquez-Mieyer PA, Christensen ML. Insulin dynamics predict body mass index and z-score response to insulin suppression or sensitization pharmacotherapy in obese children. J Pediatr 2006;148:23-9.
57. Maffeis C, Moghetti P, Grezzani A, Clementi M, Gaudino R, Tatò L et al. Insulin resistance and the persistence of obesity from childhood into adulthood. J Clin Endocrinol Metab 2002;87:71-6.
58. Travers SH, Jeffers BW, Eckel RH. Insulin resistance during puberty and future fat accumulation. J Clin Endocrinol Metab 2002;87:3814-8.
59. Li C, Ford ES, Mokdad AH, Cook S. Recent trends in waist circumference and waist- height ratio among US children and adolescents. Pediatrics 2006;118:e1390-8.
60. Ford ES, Ajani UA, Mohdad AH, The metabolic syndrome and concentrations of C-reactive protein among U.S. youth. Diabetes Care 2005;28:878-81.
61. de Ferranti SD, Gauvreau K, Ludwig DS, Newburger JW, Rifai N. Inflammation and changes in metabolic syndrome abnormalities in US adolescents: findings from the 1988-1994 and 1999-2000 National Health And Nutrition Examination Surveys. Clin Chem 2006;52: 1325-30.
62. Morrison JA, Sprecher DL, Barton BA, Waclawiw MA, Daniels SR. Overweight, fat patterning, and cardiovascular disease risk factors in black and white girls: The NHLBI growth and health study. J Pediatr 1999;135:458-64.
63. Morrison JA, Barton BA, Biro FM, Daniels SR, Sprecher DL. Overweight, fat patterning and cardiovascular disease risk factors in black and white boys. J Pediatr 1999;135:451-7.
64. Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Nad Acad Sci U S A 1984;81:3883-7.
65. Parthasarathy S, Quinn MT, Schwenke DC, Carew TE, Steinberg D. Oxidative modification of beta-very low density lipoprotein. Potential role in monocyte recruitment and foam cell formation. Arteriosclerosis 1989;9:398-404.
66. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993;91:2546-51.
67. Harrison DG, Armstrong ML, Freiman PC, Heistad DD. Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis. J Clin Invest 1987;80:1808-11.
68. Mugge A, Elwell JH, Peterson TE, Hofmeyer TG, Heistad DD, Harrison DG. Chronic treatment with polyethylene-glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits. Circ Res 1991;69:1293-300.
69. Stamler J, Neaton JD, Wentworth DN. Blood pressure (systolic and diastolic) and risk of fatal coronary heart disease. Hypertension 1989;13(5 Suppl):I2-12.
70. Chobanian AV, Lichtenstein AH, Nilakhe V, Haudenschild CC, Drago R, Nickerson C. Influence of hypertension on aortic atherosclerosis in the Watanabe rabbit. Hypertension 1989;14:203-9.
71. Dohi Y, Thiel MA, Buhler FR, Luscher TF. Activation of endothelial L-arginine pathway in resistance arteries. Effect of age and hypertension. Hypertension 1990;16:170-9.
72. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation1993;87:1468-74.
73. Crawford DW, Blankenhorn DH. Arterial wall oxygenation, oxyradicals, and atherosclerosis. Atherosclerosis 1991;89:97-108.
74. Srikumar N, Brown NJ, Hopkins PN, Jeunemaitre X, Hunt SC, Vaughan DE et al. PAI-1 in human hypertensionrelation to hypertensive groups. Am J Hypertension 2002;15:683-90.
75. Poli KA, Tofler GH, Larson MG, Evans JC, Sutherland PA, Lipinska I et al. Association of blood pressure with fibrinolytic potential in the Framingham offspring population. Circulation 2000;101:264-9.
76. Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM. C-reactive protein and the risk of developing hypertension. JAMA 2003;290:2945-51.
77. Morrison JA, Schreiber GB, Barton BA. Black girls have higher plasma insulin levels than white girls at ages 9-and 10-years, but insulin associations with CHD risk factors are stronger in white girls. Circulation 1998;98:(17Suppl)I-374-5.
78. Sinaiko A, Steinberger J, Moran A, Prineas RJ, Jacobs DR. Relation of BMI and insulin resistance to cardiovascular risk factors, inflammatory factors and oxidative stress during adolescence. Circulation 2005;111:1985-91.
79. Sinaiko AR, Steinberger J, Moran A, Hong CP, Prineas RJ, Jacobs DR Jr. Influence of insulin resistance and body mass index at age 13 on systolic blood pressure, triglycerides, and high-density lipoprotein cholesterol at age 19. Hypertension 2006;48:730-6.
80. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. New Engl J Med 1997;336:973-9.
81. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. New Engl J Med 2000;342:836-43.
82. Morrow DA, Rifai N, Antman EM, Weiner DL, McCabe CH, Cannon CP et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol 1998;31:1460-5.
83. Kuller LH, Tracy RP, Shaten J, Meilahn EN. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. Am J Epidemiol 1996;144: 537-47.
84. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000;101:1767-72.
85. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000;101:2149-53.
86. Baumann H, Gauldie J. Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. Molecular Mol Biol Med 1990;7:147-59.
87. Bermudez EA, Rifai N, Buring J, Manson JE, Ridker PM. Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol 2002;22:1668-73.
88. Langenberg C, Bergstrom J, Scheidt-Nave C, Pfeilschifter J, Barrett-Connor E. Cardiovascular death and the metabolic syndrome: role of adiposity-signaling hormones and inflammatory markers. Diabetes Care 2006;29:1363-9.
89. Wang XL, Rainwater DL, VandeBerg JF, Mitchell BD, Mahaney MC. Genetic contributions to plasma total antioxidant activity. Arterioscler Thromb Vasc Biol 2001;21:1190-5.
90. Liao F, Andalibi A, Qiao JH, Allayee H, Fogelman AM, Lusis AJ. Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice. J Clin Invest 1994;94:877-84.
91. Moran A, Steffen LM, Jacobs DR Jr, Steinberger J, Pankow JS, Hong CP et al. Relation of C-reactive protein to insulin resistance and cardiovascular risk factors in youth. Diabetes Care 2005;28:1763-8.
92. Garanty-Bogacka B, Syrenicz M, Syrenicz A, Gebala A, Walczak M. Relation of acute-phase reaction and endothelial activation to insulin resistance and adiposity in obese children and adolescents. Neuro Endocrinol Lett 2005;26:473-9.
93. Hu FB, Stampfer MJ. Is type 2 diabetes mellitus a vascular condition? Arterioscler Thromb Vasc Biol 2003;23:1715-6.
94. Ford ES. Risks for all-cause mortality, cardiovascular disease and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005;28:1769-78.
95. Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med 2006;19:812-9.
96. Stern MP. Diabetes and cardiovascular disease. The "common soil" hypothesis. Diabetes 1995;44:369-74.
97. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
98. Freeman DJ, Norrie J, Sattar N, Neely RD, Cobbe SM, Ford I et al. Pravastin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study. Circulation 2001;103:357-62.
99. Yusuf S, Gerstein H, Hoogwerf B, Pogue J, Bosch J, Wolffenbuttel BH et al. Ramipril and the development of diabetes. JAMA 2001;286:1882-5.
100. Meigs JB, Hu FB, Manson JE. Endothelial dysfunction predicts development of type 2 diabetes. Diabetes 2003;52:A58(Abstract).
101. Festa A, D'Agostino R Jr, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000;102:42-7.
102. Pradhan AD, Cook NR, Buring JE, Manson JE, Ridker PM. C-reactive protein is independently associated with fasting insulin in nondiabetic women. Arterioscler Thromb Vasc Biol 2003;23:650-5.
103. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286:327-34.
104. Barzilay JI, Abraham L, Heckbert SR, Cushman M, Kuller LH, Resnick HE et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes 2001;50:2384-9.
105. Packard CJ, O'Reilly DS, Caslake MJ, McMahon AD, Ford I, Cooney J et al. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. New Engl J Med 2000;343:1148-55.
106. Morrison JA, Friedman LA, Harlan WR, Harlan LC, Barton, BA, Schreiber GB et al. Development of the metabolic syndrome in black and white adolescent girls: A longitudinal assessment. Pediatrics 2005;116: 1178-82.
107. Cook S, Weitzman M, Auinger P, Nyugen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-94. Arch Pediatr Adoles Med 2003;157:821-7.
108. Duncan GE, Li SM, Zhou XH. Prevalence and trends of a metabolic syndrome phenotype among U.S. adolescents, 199-2000. Diabetes Care 2004;27:2438-43.
109. Cook S, Auinger P, Li C, Ford ES. Metabolic syndrome rates in United States adolescents. From the National Health and Nutrition Examination Survey, 1999-2002. J Pediatr 2008;152;165-70.
110. Ford ES, Li C, Zhao G, Pearson WS, Mokdad AH. Prevalence of the metabolic syndrome among U.S. adolescents using the definition from the International Diabetes federation. J Pediatr 2008;31:587-9.
111. Rodriquez-Moran M, Salazar-Vazquez B, Violante R, Guenero-Romero F. Metabolic syndrome among children and adolescents aged 10-18. Diabetes Care 2004;27:2516-7.
112. Golley RK, Magarey AM, Steinbeck KS, Baur LA, Daniels IA. Comparison of metabolic syndrome prevalence using six different definitions in overweight pre-pubertal children enrolled in a weight management program. Int J Obes (Lond) 2006;30:853-60.
113. Chi CH, Wang Y, Wilson DM, Robinson TN. Definition of metabolic syndrome in preadolescent girls. J Pediatr 2006;148:788-92.
114. Solberg LA, Eggen DA. Localization and sequence of development of atherosclerotic lesions in the carotid and vertebral arteries Circulation 1971;63:711-24.
115. Freedman DS, Wattigney W, Srinivasan S, Newman III WP, Tracy RE, Byers T et al. The relation of atherosclerotic lesions to antemortem and postmortem lipid levels: the Bogalusa Heart Study. Atherosclerosis 1993;104:37-46.
116. Strong JP, Malcolm G, McMahan CA, Tracy RE, Newman III WP, Herderick EE et al. Prevalence and extent of atherosclerosis in adolescents and young adults: Implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA 1999;281:727-35.
117. van der Heijden-Spek JJ, Staessen JA, Fagard RH, Hoeks AP, Boudier HA, van Bortel LM. Effect of age on brachial artery wall properties differs from the aorta and is gender dependent: a population study. Hypertension 2000;35:637-42.
118. Balkestein EJ, Staessen JA, Wang J-G, van der Heijden-Spek JJ, Van Bortel LM, Barlassina C et al. Carotid and femoral artery stiffness in relation to three candidate genes in a white population. Hypertension 2001;38: 1190-7.
119. Kimoto E, Shoji T, Shinohara K, Inaba M, Okuno Y, Miki T et al. Preferential stiffening of central over peripheral arteries in type 2 diabetes. Diabetes 2003;52:448-52.
120. Davis PH, Dawson JD, Riley WA, Lauer RM. Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle-age: The Muscatine Study. Circulation 2001;104: 2815-9.
121. Urbina EM, Srinivasan SR, Tang R, Bond MG, Kieltyka L, Berenson GS et al. Impact of multiple coronary risk factors on the intima-media thickness of different segments of carotid artery in healthy young adults: The Bogalusa Heart Study. Am J Cardiol 2002;90:953-8.
122. Budoff MJ, Flores F, Tsai J, Frandsen T, Yamamoto H, Takasu J. Measures of brachial artery distensibility in relation to coronary calcification. Am J Hypertens 2003;16:350-5.
123. Urbina EM, Kieltkya L, Tsai J, Srinivasan SR, Berenson GS. Impact of multiple cardiovascular risk factors on brachial artery distensibility in young adults: the Bogalusa Heart Study. Am J Hypertens 2005;18: 767-71.
124. Meaume S, Benetos A, Henry OF, Rudnichi A, Safar ME. Aortic pulse wave velocity predicts cardiovascular mortality in subjects >70 years of age. Arterioscl Thromb Vasc Biol 2001;21:2046-50.
125. Blacher J, Safar ME, Guerin AP, Pannier B, Marchais SJ, London GM. Aortic pulse wave velocity index and mortality in end-stage renal disease. Kidney Int 2003;63:1852-60.
126. Blacher J, Asmar R, Diane S, London GM, Safar ME. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999;33:1111-7.
127. Safar ME, Blacher J, Protogerou A, Achimastos A. Aortic pulse wave velocity: an independent marker of cardiovascular risk. Am J Geriatr Cardiol 2002;11: 295-8.
128. Mulè G, Cottone S, Mongiovì R, Cusimano P, Mezzatesta G, Seddio G et al. Influence of the metabolic syndrome on aortic stiffness in never treated hypertensive patients. Nutr Metab Cardiovasc Dis 2006;16:54-9.
129. Chan SY, Mancini GB, Kuramoto L, Schulzer M, Frohlich J, Ignaszewski A. The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease. J Am Coll Cardiol 2003;42:1037-43.
130. Li XP, Zhao SP, Zhang XY, Liu L, Gao M, Zhou QC. Protective effect of high density lipoprotein on endothelium-dependent vasodilatation. Int J Cardiol 2000;73:231-6.
131. Tonstad S, Joakimsen O, Stensland-Bugge E, Leren TP, Ose L, Russell D et al. Risk Factors Related to Carotid Intima-Media Thickness and Plaque in Children With Familial Hypercholesterolemia and Control Subjects. Arterioscler Thromb Vasc Biol 1996;16:984-91.
132. Järvisalo MJ, Harmoinena H, Hakanen M, Paakkunainen U, Viikari J, Hartiala J et al. Elevated Serum C-Reactive Protein Levels and Early Arterial Changes in Healthy Children. Arterioscler Thromb Vasc Biol 2002;22:1323-8.
133. Sorof JM, Alexandrov AV, Garami Z, Turner JL, Grafe RE, Lai D et al. Carotid ultrasonography for detection of vascular abnormalities in hypertensive children. Pediatric Nephrology 2003;18:1020-4.
134. Iannuzzi A, Licenziati MR, Acampora C, Renis M, Agrusta M, Romano L et al. Carotid artery stiffness in obese children with the metabolic syndrome. Am J Cardiol 2006;97:528-31.
135. Iannuzzi A, Licenziati MR, Acampora C, Salvatore V, Auriemma L, Romano ML et al. Increased carotid intima-media thickness and stiffness in obese children. Diabetes Care 2004;27:2506-8.
136. Woo KS, Chook P, Yu CW, Sung RY, Qiao M, Leung SS et al. Overweight in children is associated with arterial endothelial dysfunction and intima-media thickening. Int J Obes Relat Metab Disord 2004;28:852-7.
137. Urbina EM, Bean JA, Daniels SR, D'Alessio D, Dolan LM. Overweight and hyperinsulinemia provide Individual contributions to compromises in brachial artery distensibility in healthy adolescents and young adults. J Am Soc Hypertens 2007;1:200-7
138. Morrison JA, Aaronson-Friedman L, Glueck CJ, Wang P. Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25-30. years later: the Princeton LRC Follow-up Study. J Pediatr 2008;152:201-6.
139. Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z et al. 2000 CDC growth charts for the United States: Methods and development. National Center for Health Statistics. Vital Health Stat 2002;246:1-190.
140. Morrison JA, Aronson Friedman L, Gray-McGuire C. Metabolic syndrome in childhood and adult CVD 25 years later: The Princeton follow-up study. Pediatrics 2007;120:340-5.
141. Tzou WS, Douglas PS, Srinivasan SR, Bond MG, Tang R, Chen W et al. Increased subclincal atherosclerosis in young adults with metabolic syndrome: the Bogalusa Heart Study. J Am Coll Cardiol 2005;46:457-63.
142. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-94.
143. Bamshad MJ, Olson SE. Does race exist? Scientific American 2003;289:78-85.
144. SA perspectives: Racing to conclusions. Scientific American 2003;289:14.
145. Burchard EG, Ziv E, Coyle N, Gomez SL, Tang H, Karter AJ et al. The importance of race and ethnic background in biomedical research and clinical practice. N Engl J Med 2003;348:1170-5.
146. Vega GL, Clark LT, Tang A, Marcovina S, Grundy SM, Cohen JC et al. Hepatic lipase activity is lower in African American men than in white American men: effects of the 5′ flanking polymorphism in the hepatic lipase gene (LIPC). J Lipid Res 1998;39:228-32.
147. Taylor H, Liu J, Wilson G, Golden SH, Crook E, Brunson CD et al. Distinct component profiles and high risk among African Americans with the metabolic syndrome. The Jackson Heart Study. Diabetes Care 2008;10. [Epub ahead of print]. Reaven GM. The metabolic syndrome: is this diagnosis necessary. Am J Clin Nutr 2006;83:1237-47.
148. Freemark M, Bursey D. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes. Pediatrics 2001;107:E55.
149. Morrison JA, Cottingham EM, Barton BA. Metformin for weight loss in pediatric patients taking psychotropic drugs. Am J Psychiatry 2002;159:655-7.
150. Klein DJ, Cottingham EM, Sorter M, Barton BA, Morrison JA. A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents. Am J Psychiatry 2006;163:2072-9.
151. Wu RR, Zhao JP, Jin H, Shao P, Fang MS, Guo XF et al. Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial. JAMA 2008;299:185-93.